4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CAMP4 THERAPEUTICS CORPORATION (CAMP) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 48 employees. Its market capitalization is roughly $231 million. In the fiscal year ended 2025-12-31, CAMP reported $4M in revenue and ($80M) in net income.
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders.
Interactive charts & full statements → Open the CAMP valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $4M | $1M | $0M | $0M |
| Operating Income (EBIT) | ($52M) | ($53M) | ($52M) | ($45M) |
| Net Income | ($80M) | ($52M) | ($49M) | ($44M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $0M | $1M | $2M | $1M |
| Operating Income (EBIT) | ($13M) | ($13M) | ($13M) | ($13M) | ($13M) |
| Net Income | ($18M) | ($40M) | ($15M) | ($13M) | ($12M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $118M | $78M | $55M | $102M |
| Total Liabilities | $70M | $15M | $179M | $180M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CAMP viewer.
About TickerBase · Data methodology & sources